Ładuje się......
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
B-cell lymphoma 2-related protein A1 (BCL2A1) is a member of the BCL-2 family of anti-apoptotic proteins that confers resistance to treatment with anti-cancer drugs; however, there are presently no agents that target BCL2A1. The MUC1-C oncoprotein is aberrantly expressed in triple-negative breast ca...
Zapisane w:
| Wydane w: | Signal Transduct Target Ther |
|---|---|
| Główni autorzy: | , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Nature Publishing Group UK
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5948210/ https://ncbi.nlm.nih.gov/pubmed/29760958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-018-0013-x |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|